These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27329026)

  • 21. Autoantibodies to GAD, IA-2 and insulin in ICA-positive first-degree relatives of children with type 1 diabetes: a comparison between parents and siblings.
    Korhonen S; Knip MM; Kulmala P; Savola K; Akerblom HK; Knip M;
    Diabetes Metab Res Rev; 2002; 18(1):43-8. PubMed ID: 11921417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-titer autoantibodies against glutamic acid decarboxylase plus autoantibodies against insulin and IA-2 predicts insulin requirement in adult diabetic patients.
    Kasuga A; Maruyama T; Nakamoto S; Ozawa Y; Suzuki Y; Saruta T
    J Autoimmun; 1999 Mar; 12(2):131-5. PubMed ID: 10047433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes Antibody Standardization Program: evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2.
    Törn C; Mueller PW; Schlosser M; Bonifacio E; Bingley PJ;
    Diabetologia; 2008 May; 51(5):846-52. PubMed ID: 18373080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change of glutamic acid decarboxylase antibody and protein tyrosine phosphatase antibody in Chinese patients with acute-onset type 1 diabetes mellitus.
    Chao C; Huang G; Li X; Yang L; Lin J; Jin P; Luo SM; Zhang YY; Pan LL; Zhou ZG
    Chin Med J (Engl); 2013 Nov; 126(21):4006-12. PubMed ID: 24229665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple screening method for individuals at risk of developing type 1 diabetes: measurement of islet cell autoantibodies (GADA, IA-2A, and IAA) on dried capillary blood spots collected on filter paper.
    Siraj ES; Rogers DG; Gupta MK; Reddy SS
    Horm Metab Res; 2012 Oct; 44(11):855-60. PubMed ID: 22893260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
    Bottazzo GF; Bosi E; Cull CA; Bonifacio E; Locatelli M; Zimmet P; Mackay IR; Holman RR
    Diabetologia; 2005 Apr; 48(4):703-8. PubMed ID: 15765222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of Individual Positive Anti-Islet Autoantibodies from 3 Screen ICA Titer.
    Kawasaki E; Jinnouchi H; Maeda Y; Okada A; Kawai K
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
    Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of type 1 diabetes among siblings of affected children and in the general population.
    Siljander HT; Veijola R; Reunanen A; Virtanen SM; Akerblom HK; Knip M
    Diabetologia; 2007 Nov; 50(11):2272-5. PubMed ID: 17768605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies against IA-2, GAD, and topoisomerase II in type 1 diabetic patients.
    Chang YH; Shiau MY; Tsai ST; Lan MS
    Biochem Biophys Res Commun; 2004 Jul; 320(3):802-9. PubMed ID: 15240119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group.
    Kulmala P; Savola K; Petersen JS; Vähäsalo P; Karjalainen J; Löppönen T; Dyrberg T; Akerblom HK; Knip M
    J Clin Invest; 1998 Jan; 101(2):327-36. PubMed ID: 9435304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dietary risk factors for the emergence of type 1 diabetes-related autoantibodies in 21/2 year-old Swedish children.
    Wahlberg J; Vaarala O; Ludvigsson J;
    Br J Nutr; 2006 Mar; 95(3):603-8. PubMed ID: 16578935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?
    Lounici Boudiaf A; Bouziane D; Smara M; Meddour Y; Haffaf EM; Oudjit B; Chaib Mamouzi S; Aouichat Bouguerra S
    Curr Res Transl Med; 2018 Mar; 66(1):1-7. PubMed ID: 29487039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease.
    Seissler J; de Sonnaville JJ; Morgenthaler NG; Steinbrenner H; Glawe D; Khoo-Morgenthaler UY; Lan MS; Notkins AL; Heine RJ; Scherbaum WA
    Diabetologia; 1998 Aug; 41(8):891-7. PubMed ID: 9726590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus.
    Huang G; Xiang Y; Pan L; Li X; Luo S; Zhou Z
    Diabetes Metab Res Rev; 2013 Jul; 29(5):363-8. PubMed ID: 23390067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus--a nationwide study.
    Ostman J; Landin-Olsson M; Törn C; Palmer J; Lernmark A; Arnqvist H; Björk E; Bolinder J; Blohmé G; Eriksson J; Littorin B; Nyström L; Scherstén B; Sundkvist G; Wibell L
    Diabet Med; 2000 Apr; 17(4):269-74. PubMed ID: 10821292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct.
    Howson JM; Stevens H; Smyth DJ; Walker NM; Chandler KA; Bingley PJ; Todd JA
    Diabetes; 2011 Oct; 60(10):2635-44. PubMed ID: 21831970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IA-2 autoantibodies predict impending type I diabetes in siblings of patients.
    Decochez K; De Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Weets I; Vandemeulebroucke E; Truyen I; Kaufman L; Schuit FC; Pipeleers DG; Gorus FK;
    Diabetologia; 2002 Dec; 45(12):1658-66. PubMed ID: 12488955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants.
    Sosenko JM; Skyler JS; Palmer JP; Krischer JP; Cuthbertson D; Yu L; Schatz DA; Orban T; Eisenbarth G;
    Diabetes Care; 2011 Nov; 34(11):2435-7. PubMed ID: 21911777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.